![Alma Fulurija](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alma Fulurija
Corporate Officer/Principal presso Ondek Pty Ltd.
Profilo
Alma Fulurija is currently the Head of Immunology & Translational Research at Ondek Pty Ltd.
She previously worked as a Principal at Cytos Biotechnology AG.
Posizioni attive di Alma Fulurija
Società | Posizione | Inizio |
---|---|---|
Ondek Pty Ltd.
![]() Ondek Pty Ltd. Pharmaceuticals: MajorHealth Technology Ondek Pty Ltd. develops natural immune modulatory products for allergic disorders. It offers ImmBALANCE, a product for allergy indications. The firm develops core ingredient for products that will reduce the allergic response in children, adolescents and adults. The company was founded by Barry Marshall in 2005 and is headquartered in Sydney, Australia. | Corporate Officer/Principal | - |
Precedenti posizioni note di Alma Fulurija
Società | Posizione | Fine |
---|---|---|
Cytos Biotechnology AG
![]() Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Cytos Biotechnology AG engages in the development and commercialization of biopharmaceutical products. The company was founded by Wolfgang A. Renner, James E. Bailey and Hans M. Eppenberger in February 1995 and is headquartered in Zurich, Switzerland. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Cytos Biotechnology AG
![]() Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Cytos Biotechnology AG engages in the development and commercialization of biopharmaceutical products. The company was founded by Wolfgang A. Renner, James E. Bailey and Hans M. Eppenberger in February 1995 and is headquartered in Zurich, Switzerland. | Commercial Services |
Ondek Pty Ltd.
![]() Ondek Pty Ltd. Pharmaceuticals: MajorHealth Technology Ondek Pty Ltd. develops natural immune modulatory products for allergic disorders. It offers ImmBALANCE, a product for allergy indications. The firm develops core ingredient for products that will reduce the allergic response in children, adolescents and adults. The company was founded by Barry Marshall in 2005 and is headquartered in Sydney, Australia. | Health Technology |
- Borsa valori
- Insiders
- Alma Fulurija